Assistance Publique - Hôpitaux de Paris: Breast Neoplasms trials
The registry lists 30 Breast Neoplasms studies with Assistance Publique - Hôpitaux de Paris as lead sponsor. 9 are open to participants now and 0 have results posted.
Phase 2 2Phase 3 2No phase 26(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Senocohort: Identification of Predictive Biomarkers in Breast Cancer TreatmentNot yet recruitingNCT07833891
- Benchmarking Large Language Models Against Tumour Boards for Oncology Treatment RecommendationsRecruitingNCT07739121
- Long-term Evaluation of Quality of Life and Aesthetic Outcomes After Autologous Breast Reconstruction Using the Profunda Artery Perforator (PAP) FlapNot yet recruitingNCT07728565
- Performance of Anthracycline-Free Neoadjuvant Chemoimmunotherapy in Early Triple-Negative Breast CancerNot yet recruitingNCT07687446
- Breast Cancer Risk Assessment in Night Shift Workers - Implementation of a Personalized ConsultationRecruitingNCT07630935
- Real-life Evaluation of Endopredict® in Early HR+/HER2- Breast CancerRecruitingNCT07379918
- Association of Pembrolizumab Infusion Time and Efficacy in Patients With Non-metastatic Triple-negative Breast Cancer (TNBC) Treated With Neoadjuvant Chemotherapy and ImmunotherapyNot yet recruitingNCT06418139
- PARP-inhibitor on Advanced Metastatic Breast Cancer in Germline PALB2 Mutations CarriersNot yet recruitingNCT05232006Phase 2
- Evaluation of Innovative Therapeutic Approaches of Vaginal and Sexual Dysfunction After Breast Cancer TreatmentRecruitingNCT04713917Not applicable
- Molecular Signature for Breast CancerStatus unknownNCT05724407
- BENEFIT OF MECHANICAL ISCHEMIC PRECONDITIONING ON TOLERANCE OF ADIPOSE TISSUE TO ISCHEMIA REPERFUSION OF TYPE DIEP (DEEP INFERIOR EPIGASTRIC PERFORATOR) FREE FLAPS.CompletedNCT05373069Not applicable
- Breast Cancer Prevention and Screening MembershipActive, not recruitingNCT05258539Not applicable
- Circulating Fetal Cells and Breast CancerActive, not recruitingNCT04903990
- BIOPSY SCANNER LLTECH© Technology for Diagnosis of Breast CancerCompletedNCT04292821
- Advanced MR Techniques for Breast Cancer DetectionWithdrawnNCT04020523Not applicable
- Evaluation of Individual Sensitivity to the Gonadotoxicity of Chemotherapy in Young Patients With Breast CancerActive, not recruitingNCT03731845Not applicable
- Follow-up of Elderly Patients in Ambulatory SurgeryStatus unknownNCT03604666
- Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of FertilityCompletedNCT03591848Not applicable
- A Biomarker Study of Palbociclib + Fulvestrant for Second, and Third Line of Postmenopausal Women With hr+/her2- Advanced Breast CancerStatus unknownNCT03560856Phase 2
- Evaluation of Tomosynthesis for Characterization and the Management of Breast LesionsStatus unknownNCT02959398Not applicable
- Economic and Social Disparities and Breast CancerCompletedNCT02948478
- Assessment of Breast Cancer Response to Neoadjuvant Anthracycline-based Chemotherapy by FDG-PET and Molecular MarkersStatus unknownNCT02600442
- PET-CT in the Initial Staging of Breast Cancer and in the Early Assessment of Response to Neoadjuvant ChemotherapyStatus unknownNCT02599974
- Hand-held Gamma Camera in the SNOLL ProcedureCompletedNCT02101320Not applicable
- Fluoroestradiol PET Imaging in Predicting Response to Hormone Therapy of Breast CancerCompletedNCT01627704Not applicable
- The Memorial Sloan-Kettering Cancer Center (MSKCCCompletedNCT01509963
- Axillary Reverse Mapping for Breast CarcinomasCompletedNCT01146158Phase 3
- Impact of OncoDoc2 on Guideline Compliance in the Management of Breast CancerCompletedNCT00728442Not applicable
- Determination of Predictive Value of Echography Doppler AbnormalitiesStatus unknownNCT00714909
- PET and MRI in the Follow-up of Neoadjuvant Chemotherapy of Breast CancerCompletedNCT00236275Phase 3